Page last updated: 2024-10-20

trimethyloxamine and Bowel Diseases, Inflammatory

trimethyloxamine has been researched along with Bowel Diseases, Inflammatory in 7 studies

trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.

Research Excerpts

ExcerptRelevanceReference
"Choline is a water-soluble nutrient essential for human life."2.66The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. ( Allison, J; Arboleya, S; Arias, JL; Arias, N; Gueimonde, M; Higarza, SG; Kaliszewska, A, 2020)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Kul, S2
Caliskan, Z2
Guvenc, TS2
Celik, FB2
Sarmis, A2
Atici, A2
Konal, O2
Akıl, M2
Cumen, AS2
Bilgic, NM2
Yilmaz, Y2
Caliskan, M2
Banno, Y1
Nomura, M1
Hara, R1
Asami, M1
Tanaka, K1
Mukai, Y1
Tomata, Y1
Papa, A1
Santini, P1
De Lucia, SS1
Maresca, R1
Porfidia, A1
Pignatelli, P1
Gasbarrini, A1
Violi, F1
Pola, R1
Arias, N1
Arboleya, S1
Allison, J1
Kaliszewska, A1
Higarza, SG1
Gueimonde, M1
Arias, JL1
Yue, C1
Yang, X1
Li, J1
Chen, X1
Zhao, X1
Chen, Y1
Wen, Y1
Wilson, A1
Teft, WA1
Morse, BL1
Choi, YH1
Woolsey, S1
DeGorter, MK1
Hegele, RA1
Tirona, RG1
Kim, RB1
Takis, PG1
Oraiopoulou, ME1
Konidaris, C1
Troganis, AN1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
New Insight and Knowledge on Anti-inflammatory Effectiveness of Dietary Phenolics (NIKE)[NCT03000101]18 participants (Actual)Interventional2017-01-19Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for trimethyloxamine and Bowel Diseases, Inflammatory

ArticleYear
Trimethylamine N-oxide and risk of inflammatory bowel disease: A Mendelian randomization study.
    Medicine, 2023, Aug-25, Volume: 102, Issue:34

    Topics: Genome-Wide Association Study; Humans; Inflammatory Bowel Diseases; Mendelian Randomization Analysis

2023
Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies.
    Thrombosis research, 2023, Volume: 232

    Topics: Dysbiosis; Endotoxemia; Gastrointestinal Diseases; Humans; Inflammatory Bowel Diseases; Lipopolysacc

2023
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.
    Nutrients, 2020, Aug-05, Volume: 12, Issue:8

    Topics: Animals; Biological Availability; Cardiovascular Diseases; Choline; Diet; Dysbiosis; Gastrointestina

2020

Other Studies

4 other studies available for trimethyloxamine and Bowel Diseases, Inflammatory

ArticleYear
Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease.
    Microvascular research, 2023, Volume: 146

    Topics: Biomarkers; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Microbiome; Humans; Inflammation; I

2023
Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease.
    Microvascular research, 2023, Volume: 146

    Topics: Biomarkers; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Microbiome; Humans; Inflammation; I

2023
Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease.
    Microvascular research, 2023, Volume: 146

    Topics: Biomarkers; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Microbiome; Humans; Inflammation; I

2023
Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease.
    Microvascular research, 2023, Volume: 146

    Topics: Biomarkers; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Microbiome; Humans; Inflammation; I

2023
Trimethylamine N-oxide prime NLRP3 inflammasome via inhibiting ATG16L1-induced autophagy in colonic epithelial cells.
    Biochemical and biophysical research communications, 2017, 08-19, Volume: 490, Issue:2

    Topics: Autophagy; Autophagy-Related Proteins; Cell Line; Colon; Down-Regulation; Humans; Inflammatory Bowel

2017
Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Case-Control Studies; Female; Humans; Inflam

2015
(1)H-NMR based metabolomics study for the detection of the human urine metabolic profile effects of Origanum dictamnus tea ingestion.
    Food & function, 2016, Sep-14, Volume: 7, Issue:9

    Topics: Adult; Biomarkers; Citric Acid; Creatinine; Crohn Disease; Ethanol; Female; Greece; Hippurates; Huma

2016